Target intelligence / Profile preview

Ubiquitin specific peptidase 9, Y-linked pseudogene 20 (USP9YP20)

Target: USP9YP20
Molecular classification: Pseudogene

Overview

Ubiquitin specific peptidase 9, Y-linked pseudogene 20 (USP9YP20) is a Y-chromosome pseudogene derived from the ancestral USP9Y locus. Unlike USP9Y, which encodes a deubiquitinase important for male germ cell development and fertility, USP9YP20 does not encode an active protein and is considered functionally inert. Pseudogenes such as USP9YP20 typically arise via gene duplication or retrotransposition and retain sequence similarity to the parent gene but lack biological activity. There is no current evidence for USP9YP20 participation in disease, cellular pathways, or as a drug target[1][5].

Other names: Ubiquitin specific peptidase 9, Y-linked pseudogene 20USP9Y pseudogene 20

Mechanism of action

None. As a pseudogene, there are no mechanisms of action relevant to drug targeting.

Biological functions

As a pseudogene, USP9YP20 does not encode a functional protein and has no direct, characterized biological activity.

Disease associations

None directly known.

Safety considerations

None relevant, as it is not an active therapeutic target.

Interacting drugs

No drugs are known to interact with this pseudogene.

Biomarkers

USP9YP20 is not used as a biomarker for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on Ubiquitin specific peptidase 9, Y-linked pseudogene 20 (USP9YP20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin specific peptidase 9, Y-linked pseudogene 20 (USP9YP20).

Explore the full profile